176 related articles for article (PubMed ID: 25560589)
41. Lack of analgesic efficacy of spinal ondansetron on thermal and mechanical hypersensitivity following spinal nerve ligation in the rat.
Peters CM; Hayashida K; Ewan EE; Nakajima K; Obata H; Xu Q; Yaksh TL; Eisenach JC
Brain Res; 2010 Sep; 1352():83-93. PubMed ID: 20637741
[TBL] [Abstract][Full Text] [Related]
42. Mediation by 5-HT3 receptors of an excitatory effect of 5-HT on dorsal vagal preganglionic neurones in anaesthetized rats: an ionophoretic study.
Wang Y; Ramage AG; Jordan D
Br J Pharmacol; 1996 Aug; 118(7):1697-704. PubMed ID: 8842434
[TBL] [Abstract][Full Text] [Related]
43. Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.
Hagan RM; Jones BJ; Jordan CC; Tyers MB
Br J Pharmacol; 1990 Feb; 99(2):227-32. PubMed ID: 1691672
[TBL] [Abstract][Full Text] [Related]
44. Fluvoxamine alleviates seizure activity and downregulates hippocampal GAP-43 expression in pentylenetetrazole-kindled mice: role of 5-HT3 receptors.
Alhaj MW; Zaitone SA; Moustafa YM
Behav Pharmacol; 2015 Jun; 26(4):369-82. PubMed ID: 25590967
[TBL] [Abstract][Full Text] [Related]
45. Serotonin Plays a Key Role in the Development of Opioid-Induced Hyperalgesia in Mice.
Sasaki M; Kamiya Y; Bamba K; Onishi T; Matsuda K; Kohno T; Kurabe M; Furutani K; Yanagimura H
J Pain; 2021 Jun; 22(6):715-729. PubMed ID: 33465503
[TBL] [Abstract][Full Text] [Related]
46. Serotonergic agents act on 5-HT
Faingold CL; Randall M; Zeng C; Peng S; Long X; Feng HJ
Epilepsy Behav; 2016 Nov; 64(Pt A):166-170. PubMed ID: 27743549
[TBL] [Abstract][Full Text] [Related]
47. Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the rat.
Adrien J; Tissier MH; Lanfumey L; Haj-Dahmane S; Jolas T; Franc B; Hamon M
Neuropharmacology; 1992 Jun; 31(6):519-29. PubMed ID: 1407392
[TBL] [Abstract][Full Text] [Related]
48. Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist.
Roychoudhury M; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):677-83. PubMed ID: 9121224
[TBL] [Abstract][Full Text] [Related]
49. Influence of tramadol on neurotransmitter systems of the rat brain.
Frink MC; Hennies HH; Englberger W; Haurand M; Wilffert B
Arzneimittelforschung; 1996 Nov; 46(11):1029-36. PubMed ID: 8955860
[TBL] [Abstract][Full Text] [Related]
50. The effect of a 5-HT3 receptor antagonist, ondansetron, on brain stimulation reward, and its interaction with direct and indirect stimulants of central dopaminergic transmission.
Montgomery AM; Rose IC; Herberg LJ
J Neural Transm Gen Sect; 1993; 91(1):1-11. PubMed ID: 8383982
[TBL] [Abstract][Full Text] [Related]
51. The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT
Dale E; Grunnet M; Pehrson AL; Frederiksen K; Larsen PH; Nielsen J; Stensbøl TB; Ebert B; Yin H; Lu D; Liu H; Jensen TN; Yang CR; Sanchez C
Brain Res; 2018 Jun; 1689():1-11. PubMed ID: 29274875
[TBL] [Abstract][Full Text] [Related]
52. 5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.
Huang X; Nichols DE
Eur J Pharmacol; 1993 Jul; 238(2-3):291-6. PubMed ID: 8104811
[TBL] [Abstract][Full Text] [Related]
53. Activation of serotonin-3 receptors increases dopamine release within the ventral tegmental area of Wistar and alcohol-preferring (P) rats.
Liu W; Thielen RJ; Rodd ZA; McBride WJ
Alcohol; 2006 Nov; 40(3):167-76. PubMed ID: 17418696
[TBL] [Abstract][Full Text] [Related]
54. Hypoglossal nerve response to 5-HT3 drugs injected into the XII nucleus and vena cava in the rat.
Fenik P; Ogawa H; Veasey SC
Sleep; 2001 Dec; 24(8):871-8. PubMed ID: 11766156
[TBL] [Abstract][Full Text] [Related]
55. Serotonin enhances urinary bladder nociceptive processing via a 5-HT3 receptor mechanism.
Hall JD; DeWitte C; Ness TJ; Robbins MT
Neurosci Lett; 2015 Sep; 604():97-102. PubMed ID: 26247537
[TBL] [Abstract][Full Text] [Related]
56. Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo.
Esteban S; Lladó J; Sastre-Coll A; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):135-43. PubMed ID: 10494882
[TBL] [Abstract][Full Text] [Related]
57. Ondansetron Does Not Reduce Withdrawal in Patients With Physical Dependence on Chronic Opioid Therapy.
Chu LF; Sun J; Clemenson A; Erlendson MJ; Rico T; Cornell E; Obasi H; Sayyid ZN; Encisco EM; Yu J; Gamble JG; Carroll I; Clark JD
J Addict Med; 2017; 11(5):342-349. PubMed ID: 28514235
[TBL] [Abstract][Full Text] [Related]
58. A 5-HT3 receptor antagonist potentiates the behavioral, neurochemical and electrophysiological actions of an SSRI antidepressant.
Bétry C; Overstreet D; Haddjeri N; Pehrson AL; Bundgaard C; Sanchez C; Mørk A
Pharmacol Biochem Behav; 2015 Apr; 131():136-42. PubMed ID: 25697477
[TBL] [Abstract][Full Text] [Related]
59. 5-HT3-like receptors in the rat medial prefrontal cortex: an electrophysiological study.
Ashby CR; Minabe Y; Edwards E; Wang RY
Brain Res; 1991 Jun; 550(2):181-91. PubMed ID: 1679370
[TBL] [Abstract][Full Text] [Related]
60. Effects of 5-HT3 agonists on reproductive behaviors in rats.
Tanco SA; Watson NV; Gorzalka BB
Psychopharmacology (Berl); 1994 Jun; 115(1-2):245-8. PubMed ID: 7862902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
